|
Author, year | Study type | N VTE/N total | Location of study | Timing of study | Pharmacologic anticoagulation | Timing of VTE | Outcome | Diagnosis |
|
Bakhru, 2012 | Retrospective cohort | 69/641 | Michigan, USA; University of Michigan Medical Center | 1999–2009 | Unknown | Postoperative | DVT | Symptomatic evaluation |
|
Black, 2007 | Retrospective cohort | 57/559 | New York, USA; Gynecologic Service Database of Memorial Sloan-Kettering Cancer Center | 01/1999–04/2015 | Heparin given at surgeon’s discretion | Diagnosis to 30 days Postoperative | PE, DVT | Symptomatic evaluation |
|
Duska, 2009 | Retrospective cohort | 37/129 | Massachusetts, USA; Massachusetts General Hospital | 1994–2004 | All patients received pre- and postoperative subcutaneous heparin | Over the clinical course of disease until death, loss to follow-up, or 2004 | PE, DVT | Symptomatic evaluation |
|
Ebina, 2018 | Prospective cohort | 25/110 | Kobe, Japan; Kobe University Hospital | 6/2010–12/2016 | Unknown | Prior to the start of any treatment | DVT, DVT, and PE | Screening with ultrasound and CT scan |
|
Fotopoulou, 2009 | Retrospective cohort | 37/525 | Germany; two clinical trials of the North-Eastern German Society of Gynecologic Oncology Ovarian Cancer Study Group | 09/1999–08/2005 | Prophylactic care to patient’s physician preference | During 2nd line topotecan-based chemotherapy | VTE | Symptomatic evaluation |
|
Gunderson, 2014 | Retrospective cohort | 94/586 | Oklahoma, USA; University of Oklahoma Health Sciences Center | 01/1996–06/2011 | Unknown | At diagnosis through last follow-up | PE, DVT | Symptomatic evaluation |
|
Heath, 2015 | Retrospective cohort | 19/397 | London, UK; Royal Marsden Hospital and St. George’s Hospital | 01/2006–12/2012 | Unknown | Pre- and postoperative | PE, DVT | Screening and symptomatic evaluation |
|
Kawaguchi, 2012 | Retrospective cohort | 14/87 | Nara, Japan; Shizuokas Cancer Center Hospital | 07/2007–10/2008 | Unknown | preoperative and pretreatment | DVT, DVT, and PE | Screening using ultrasound and CT scan |
|
Kodama, 2012 | Retrospective cohort | 23/114 | Okayama, Japan; Okayama University Hospital | 08/2005–08/2011 | Unknown | preoperative | VTE | High D-dimer and clinically symptomatic evaluation |
|
Mereu, 2009 | Retrospective cohort | 16/203 | Pavia, Italy; San Matteo Hospital | 1990–2004 | Surgical patients received heparin for 7 days after surgery | During chemotherapy treatment | PE, DVT | Evaluated on clinical suspicion of disease |
|
Mokri, 2013 | Retrospective cohort | 35/569 | Minnesota, USA; Mayo Clinic Hospital | 01/2003–12/2008 | To surgeon’s preference | Postoperative | PE, DVT | Symptomatic evaluation |
|
Saadeh, 2013 | Retrospective cohort | 33/344 | Dublin, Ireland; St. Jame Hospital | 2006–2010 | Surgical patients received heparin | Diagnosis to 8 months, variable treatments received in time frame | PE, DVT | Routine staging CT and symptomatic evaluation |
|
Sakurai, 2017 | Prospective cohort | 31/128 | Tsukuba, Japan; University of Tsukuba Hospital | 11/2004–12/2010 | Unknown | Postoperative | DVT, DVT, and PE | Screening with ultrasound, CT and MRI |
|
Satoh, 2007 | Prospective cohort | 18/72 | Tsukuba, Japan; University of Tsukuba Hospital | 11/2004–03/2007 | Unknown | Prior to treatment and surgery | DVT, PE | Screening with ultrasound, CT and MRI |
|
Suzuki, 2010 | Retrospective cohort | 21/144 | Kanagawa, Japan; St. Marianna University School of Medicine Department of Obstetrics and Gynecology | 01/2005–06/2008 | Some patients received presurgery anticoagulation | Preoperative | DVT, PE | Screening CT and ultrasound in patients with high D-dimer levels before surgery |
|
Tateo, 2005 | Retrospective cohort | 42/253 | Pavia, Italy; San Matteo Hospital | 1990–2001 | Heparin for at least 7 days after surgery | Diagnosis until follow-up; average follow-up or time even was 24.3 months | DVT, PE | Symptomatic evaluation on clinical suspicion |
|
Uno, 2007 | Prospective cohort | 10/32 | Tsukuba, Japan; University of Tsukuba Hospital | 01/2004 | Unknown | preoperative | DVT, DVT, and PE | Screening with ultrasound, CT and MRI |
|
Wagner, 2014 | Retrospective cohort | 140/860 | Minnesota, USA; Mayo Clinic Hospital | 01/2003–12/2011 | To surgeon’s preference | 6 months after primary debulking surgery | DVT, PE | Symptomatic evaluation; self-report; next-of-kin report; autopsy |
|
Wu, 2013 | Retrospective cohort | 13/183 | Shanghai, China; Fudan University Cancer Hospital | 07/2007–01/2011 | Unknown | Diagnosis to at least 5 months postoperative | DVT, PE | Self-report by telephone and outpatient chart review (symptomatic evaluation) |
|
Zhang, 2018 | Retrospective cohort | 35/388 | Shandong, China; Qilu Hospital of Shandong University | 01/2014–01/2017 | Preoperative VTE cases were given heparin, 7 days of heparin given after surgery | Diagnosis to last chemotherapy treatment (>6 months) | DVT, PE | Preoperative screening with ultrasound and symptomatic evaluation after surgery |
|